These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9773394)

  • 1. Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data.
    Gagnon RC; Peterson JJ
    J Pharmacokinet Biopharm; 1998 Feb; 26(1):87-102. PubMed ID: 9773394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Review of a technic for the estimation of area under the concentration curve in pharmacokinetic analysis].
    Bourget P; Delouis JM
    Therapie; 1993; 48(1):1-5. PubMed ID: 8356539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimising time samples for determining area under the curve of pharmacokinetic data using non-compartmental analysis.
    Hughes JH; Upton RN; Reuter SE; Phelps MA; Foster DJR
    J Pharm Pharmacol; 2019 Nov; 71(11):1635-1644. PubMed ID: 31412422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioequivalence studies of galantamine hydrobromide dispersible tablet in healthy male Chinese volunteers.
    Zhang LJ; Fang XL; Li XN; Wang QS; Han LM; Zhang ZW; Sha XY
    Drug Dev Ind Pharm; 2007 Mar; 33(3):335-40. PubMed ID: 17454066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of numerical integration algorithms for the estimation of the area under the curve (AUC) in pharmacokinetic studies.
    Yu Z; Tse FL
    Biopharm Drug Dispos; 1995 Jan; 16(1):37-58. PubMed ID: 7711282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage and precision of confidence intervals for area under the curve using parametric and non-parametric methods in a toxicokinetic experimental design.
    Bonate PL
    Pharm Res; 1998 Mar; 15(3):405-10. PubMed ID: 9563069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an optimal destructive sampling design for noncompartmental AUC estimation.
    Vandenhende F; Comblain M; Delsemme MH; Dewe W; Hoffman WP; Boulanger B
    J Pharmacokinet Biopharm; 1999 Apr; 27(2):191-212. PubMed ID: 10567955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tenofovir plasma and tissue exposure using a population pharmacokinetic model and bootstrap: a simulation study from observed data.
    Collins JW; Heyward Hull J; Dumond JB
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):631-640. PubMed ID: 29119381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Numerical estimation of the noncompartmental pharmacokinetic parameters variance and coefficient of variation of residence times.
    Purves RD
    J Pharm Sci; 1994 Feb; 83(2):202-5. PubMed ID: 8169789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sampling intervals verification in pharmacokinetics studies.
    Grabowski T; Jaroszewski JJ; Sasinowska-Motyl M; Bujalska-Zadrożny M
    Drug Res (Stuttg); 2014 Aug; 64(8):442-7. PubMed ID: 24327523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-compartmental analysis.
    Gabrielsson J; Weiner D
    Methods Mol Biol; 2012; 929():377-89. PubMed ID: 23007438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.
    Fleming DH; Mathew BS; Prasanna S; Annapandian VM; John GT
    Ther Drug Monit; 2011 Apr; 33(2):165-70. PubMed ID: 21383656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative pharmacokinetic analysis based on nonlinear mixed effect model].
    Li LJ; Li XX; Xu L; Lü YH; Chen JC; Zheng QS
    Yao Xue Xue Bao; 2011 Apr; 46(4):447-53. PubMed ID: 21751499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and comparative bioavailability of two metformin formulations after single-dose administration in healthy subjects.
    Atanasova I; Bozhinova K; Todorova D; Terziivanov D
    Clin Drug Investig; 2003; 23(11):743-9. PubMed ID: 17536888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial versus sparse sampling in toxicokinetic studies.
    Tse FL; Nedelman JR
    Pharm Res; 1996 Jul; 13(7):1105-8. PubMed ID: 8842053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC).
    Purves RD
    J Pharmacokinet Biopharm; 1992 Jun; 20(3):211-26. PubMed ID: 1522479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative computer simulation study of three different sparse-sampling methods for the estimation of steady-state area under the concentration-time curve (AUC) and maximum concentration (Cmax) in toxicokinetics.
    Mahmood I
    J Pharm Sci; 1997 May; 86(5):579-83. PubMed ID: 9145382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An extension of Satterthwaite's approximation applied to pharmacokinetics.
    Nedelman JR; Jia X
    J Biopharm Stat; 1998 May; 8(2):317-28. PubMed ID: 9598425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.